Multidrug resistance-associated protein 4 in pharmacology: Overview of its contribution to pharmacokinetics, pharmacodynamics and pharmacogenetics

Life Sci. 2019 Aug 15:231:116540. doi: 10.1016/j.lfs.2019.06.015. Epub 2019 Jun 7.

Abstract

MRP4 is an ABC membrane transporter involved in clinical outcomes as it is located in many tissues that manages the transport and the elimination of many drugs. This review explores the implication of MRP4 in clinical pharmacology and the importance of its genetic variability. Although there is no specific recommendation regarding the study of MRP4 in drug development, it should be considered when drugs are eliminated by the kidney or liver or when drug-drug interactions are expected.

Keywords: Anti-infectious and anti-cancer drugs; Drug-drug interactions; Multidrug resistance-associated protein 4; Pharmacogenetics.

Publication types

  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacokinetics
  • Antineoplastic Agents / pharmacology*
  • Antiviral Agents / pharmacokinetics
  • Antiviral Agents / pharmacology*
  • Drug Interactions
  • Humans
  • Multidrug Resistance-Associated Proteins / genetics
  • Multidrug Resistance-Associated Proteins / metabolism*
  • Pharmacogenetics
  • Pharmacokinetics
  • Pharmacology

Substances

  • ABCC4 protein, human
  • Antineoplastic Agents
  • Antiviral Agents
  • Multidrug Resistance-Associated Proteins